Camrelizumab Combined With Apatinib Mesylate and TACE in the Perioperative Treatment of Hepatocellular Carcinoma

Name: Camrelizumab Combined With Apatinib Mesylate and TACE in the Perioperative Treatment of Hepatocellular Carcinoma
License: Public Domain

The First Affiliated Hospital with Nanjing Medical University

ClinicalTrials.gov · Datasets · License: Public Domain

hepatocellular carcinoma, immunotherapy, preoperative

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 668821
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.